Characteristics and Methods Used For Developing the 11 Clinical Practice Guidelines.

NR: Not reported. SOA: South Africa; IND: India; POL: Poland; MAL: Malaysia; EUR: Europe; JAP: Japan; LAT: Latin America; AUS: Australia; CAN: Canada, SAU: Saudi Arabia and NICE (The UK's National Institute for Health and Clinical Excellence). *The ESH Reappraisal in 2009 cited only 1 review (4 reviews were cited in 2007). **Produced by the Hypertension Cochrane Review Group calculated for up to one year before the date of publication of the CPGs when the search date was not reported. ***The total number of reviews available at that time was 41 but two reviews were excluded because they were judged as irrelevant. ****The updated version of Murlow's review was published in 2008 but the 2000 version was the one cited.